ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

WELLINGTON MANAGEMENT GROUP LLP's Holding History (CIK: 0000902219)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 2,504,000 Value ($000) $4,130 Avg Close — Range —
Q2 2025
Shares 18,208,000 Value ($000) $23,753 Avg Close — Range —
Q1 2025
Shares 15,718,000 Value ($000) $18,135 Avg Close — Range —
Q4 2024
Shares 19,075,000 Value ($000) $20,398 Avg Close — Range —
Q3 2024
Shares 18,730,000 Value ($000) $21,940 Avg Close — Range —
Q2 2024
Shares 19,600,000 Value ($000) $21,177 Avg Close — Range —
Q1 2024
Shares 21,900,000 Value ($000) $20,593 Avg Close — Range —
Q4 2023
Shares 11,080,000 Value ($000) $10,919 Avg Close — Range —
Q3 2023
Shares 8,267,000 Value ($000) $7,630 Avg Close — Range —